IGF1R and non-small cell lung carcinoma: This is reminiscent of a report from Ajona and colleagues, who demonstrated that the combined inhibition of IGF1R and PD-1 synergistically reduced tumor growth in mice injected with non-small-cell lung cancer (NSCLC) cells [85].